These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 32399286)

  • 1. Weight Change and Its Association with Cardiometabolic Risk Markers in Overweight and Obese Women.
    Ahmad Zamri L; Appannah G; Zahari Sham SY; Mansor F; Ambak R; Mohd Nor NS; Aris T
    J Obes; 2020; 2020():3198326. PubMed ID: 32399286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of a community-based intervention for weight loss on cardiometabolic risk factors among overweight and obese women in a low socio-economic urban community: findings of the MyBFF@home.
    Liyana AZ; Appannah G; Sham SYZ; Fazliana M; Nor NSM; Ambak R; Samad AA; Dahlan NY; Aris T
    BMC Womens Health; 2018 Jul; 18(Suppl 1):126. PubMed ID: 30066628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of lifestyle intervention improve cardiovascular disease risk factors in community-based menopausal transition and early postmenopausal women in China.
    Wu L; Chen R; Ma D; Zhang S; Walton-Moss B; He Z
    Menopause; 2014 Dec; 21(12):1263-8. PubMed ID: 24781851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An introduction to the My Body is Fit and Fabulous at home (MyBFF@home): a community-based weight loss intervention study among Malaysian housewives.
    Mohamad Nor NS; Ambak R; Aris T
    BMC Womens Health; 2018 Jul; 18(Suppl 1):107. PubMed ID: 30066634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of rimonabant for improvement of multiple cardiometabolic risk factors in overweight/obese patients: pooled 1-year data from the Rimonabant in Obesity (RIO) program.
    Van Gaal L; Pi-Sunyer X; Després JP; McCarthy C; Scheen A
    Diabetes Care; 2008 Feb; 31 Suppl 2():S229-40. PubMed ID: 18227491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a Lifestyle Intervention Program With Energy-Restricted Mediterranean Diet and Exercise on Weight Loss and Cardiovascular Risk Factors: One-Year Results of the PREDIMED-Plus Trial.
    Salas-Salvadó J; Díaz-López A; Ruiz-Canela M; Basora J; Fitó M; Corella D; Serra-Majem L; Wärnberg J; Romaguera D; Estruch R; Vidal J; Martínez JA; Arós F; Vázquez C; Ros E; Vioque J; López-Miranda J; Bueno-Cavanillas A; Tur JA; Tinahones FJ; Martín V; Lapetra J; Pintó X; Daimiel L; Delgado-Rodríguez M; Matía P; Gómez-Gracia E; Díez-Espino J; Babio N; Castañer O; Sorlí JV; Fiol M; Zulet MÁ; Bulló M; Goday A; Martínez-González MÁ;
    Diabetes Care; 2019 May; 42(5):777-788. PubMed ID: 30389673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Text messaging (SMS) as a tool to facilitate weight loss and prevent metabolic deterioration in clinically healthy overweight and obese subjects: a randomised controlled trial.
    Silina V; Tessma MK; Senkane S; Krievina G; Bahs G
    Scand J Prim Health Care; 2017 Sep; 35(3):262-270. PubMed ID: 28812403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term effects of a preconception lifestyle intervention on cardiometabolic health of overweight and obese women.
    Wekker V; Huvinen E; van Dammen L; Rono K; Painter RC; Zwinderman AH; van de Beek C; Sarkola T; Mol BWJ; Groen H; Hoek A; Koivusalo SB; Roseboom TJ; Eriksson JG
    Eur J Public Health; 2019 Apr; 29(2):308-314. PubMed ID: 30380017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiometabolic and behavioural risk factors in young overweight women identified with simple anthropometric measures.
    Share BL; Naughton GA; Obert P; Peat JK; Kemp JG
    J Sci Med Sport; 2014 Nov; 17(6):656-61. PubMed ID: 24200930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between Changes in Postpartum Weight and Waist Circumference and Changes in Cardiometabolic Risk Factors Among Women With Recent Gestational Diabetes.
    Nicklas JM; Rosner BA; Zera CA; Seely EW
    Prev Chronic Dis; 2019 Apr; 16():E47. PubMed ID: 31002638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial.
    Pi-Sunyer FX; Aronne LJ; Heshmati HM; Devin J; Rosenstock J;
    JAMA; 2006 Feb; 295(7):761-75. PubMed ID: 16478899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of co-morbidity on body composition changes after weight loss intervention among overweight housewives: a follow-up study of the MyBFF@home.
    Abdul Aziz NS; Shahar S; Ambak R; Mohamad Nor NS; Jamil AT; Aris T
    BMC Womens Health; 2018 Jul; 18(Suppl 1):115. PubMed ID: 30066631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal factor analysis reveals a distinct clustering of cardiometabolic improvements during intensive, short-term dietary and exercise intervention in obese children and adolescents.
    Hobkirk JP; King RF; Gately P; Pemberton P; Smith A; Barth JH; Carroll S
    Metab Syndr Relat Disord; 2012 Feb; 10(1):20-5. PubMed ID: 21936669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does body mass index modify the association between physical activity and screen time with cardiometabolic risk factors in adolescents? Findings from a country-wide survey.
    Cureau FV; Ekelund U; Bloch KV; Schaan BD
    Int J Obes (Lond); 2017 Apr; 41(4):551-559. PubMed ID: 27867201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Waist circumference reduction and cardiovascular benefits during weight loss in women.
    Han TS; Richmond P; Avenell A; Lean ME
    Int J Obes Relat Metab Disord; 1997 Feb; 21(2):127-34. PubMed ID: 9043967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Weight-Loss Diets, Adiponectin, and Changes in Cardiometabolic Risk in the 2-Year POUNDS Lost Trial.
    Ma W; Huang T; Zheng Y; Wang M; Bray GA; Sacks FM; Qi L
    J Clin Endocrinol Metab; 2016 Jun; 101(6):2415-22. PubMed ID: 27055193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in risk factors for cardiovascular disease with body fat loss in obese women.
    Krebs JD; Evans S; Cooney L; Mishra GD; Fruhbeck G; Finer N; Jebb SA
    Diabetes Obes Metab; 2002 Nov; 4(6):379-87. PubMed ID: 12406035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do differences in waist circumference modify the relationships among body mass index, insulin resistance, and related cardiometabolic risk factors in apparently healthy women?
    Salazar MR; Carbajal HA; Espeche WG; Balbín E; Aizpurúa M; Marillet AG; Reaven GM
    J Am Coll Nutr; 2014; 33(1):32-8. PubMed ID: 24533606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of a lifestyle intervention in obese infertile women on cardiometabolic health and quality of life: A randomized controlled trial.
    van Dammen L; Wekker V; van Oers AM; Mutsaerts MAQ; Painter RC; Zwinderman AH; Groen H; van de Beek C; Muller Kobold AC; Kuchenbecker WKH; van Golde R; Oosterhuis GJE; Vogel NEA; Mol BWJ; Roseboom TJ; Hoek A;
    PLoS One; 2018; 13(1):e0190662. PubMed ID: 29324776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diet-Induced Weight Loss Reduces DNA Damage and Cardiometabolic Risk Factors in Overweight/Obese Women with Polycystic Ovary Syndrome.
    Soares NP; Santos AC; Costa EC; Azevedo GD; Damasceno DC; Fayh AP; Lemos TM
    Ann Nutr Metab; 2016; 68(3):220-7. PubMed ID: 27073909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.